首页|肿瘤相关巨噬细胞在肾细胞癌中的作用及研究进展

肿瘤相关巨噬细胞在肾细胞癌中的作用及研究进展

扫码查看
肾细胞癌(RCC)是最常见的泌尿系恶性肿瘤之一,尽管靶向疗法和免疫疗法已用于治疗RCC多年,但目前仍未达到满意的效果.虽然RCC的发病机制已研究多年,然而其机制仍未明确.肿瘤相关巨噬细胞(TAMs)是肿瘤微环境中重要的炎性细胞.TAMs具有高度可塑性,不同表型的TAMs在RCC的发生发展中具有不同的效应,同时TAMs与其他免疫细胞间复杂的相互作用也严重影响了 RCC的治疗效果.本文对TAMs促进肿瘤的血管生成、侵袭转移、抑制机体对肿瘤的免疫作用和耐药性等机制,以及以TAMs为靶点新的治疗策略,包括抑制TAMs募集和TAMs耗竭、M2 TAMs向M1 TAMs转化和TAMs作为药物载体的新进展进行综述.
Role of tumor-associated macrophages in renal cell carcinoma and progress of research thereon
Renal cell carcinoma(RCC)is one of the most common urological malignancies,and although tar-geted therapies and immunotherapies have been used to treat RCC for many years,the results have not been satisfacto-ry.Although the pathogenesis of RCC has been studied for many years,the mechanism remains unclear.Tumor-associ-ated macrophages(TAMs)are important inflammatory cells in the tumor microenvironment.TAMs are highly plastic,and different phenotypes of TAMs have different effects in the development of renal cell carcinoma.Meanwhile,the complex interactions between TAMs and other immune cells also seriously affect the therapeutic effects of renal cell car-cinoma.In this paper,we review the mechanisms by which TAMs promote tumor angiogenesis,invasion and metasta-sis,inhibit the body's immune effects on tumors and drug resistance,as well as new therapeutic strategies targeting TAMs,including inhibition of TAM recruitment and depletion,conversion of M2 TAMs to M1 TAMs,and new ad-vances in the use of TAMs as drug carriers.

Renal cell carcinomaTumor microenvironmentTumor-associated macrophagesTargeted therapy

杨嘉鑫、施鸿金、郑杨煌、曾丹、王海峰、左毅刚、王剑松、张劲松

展开 >

昆明医科大学第二附属医院泌尿外科,昆明 650101

肾细胞癌 肿瘤微环境 肿瘤相关巨噬细胞 靶向治疗

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(12)